Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis by Djukic, Marija et al.
ORIGINAL COMMUNICATION
Cerebrospinal ﬂuid ﬁndings in adults with acute Lyme
neuroborreliosis
Marija Djukic • Carsten Schmidt-Samoa •
Peter Lange • Annette Spreer • Katja Neubieser •
Helmut Eiffert • Roland Nau • Holger Schmidt
Received: 7 May 2011/Revised: 6 August 2011/Accepted: 10 August 2011/Published online: 6 September 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Presence of BB-speciﬁc antibodies in the
cerebrospinal ﬂuid (CSF) with evidence of their intrathecal
production in conjunction with the white cell count in the
CSF and typical clinical symptoms is the traditional diag-
nostic gold standard of Lyme neuroborreliosis (LNB). Few
data are available on the CSF lactate concentration in
European adults with the diagnosis of acute LNB. The
objective of the study was to investigate the CSF changes
during acute LNB. Routine CSF parameters [leukocyte
count, protein, lactate and albumin concentrations, CSF/
serum quotients of albumin (QAlb), IgG, IgA and IgM, and
oligoclonal IgG bands] and the Borrelia burgdorferi (BB)-
speciﬁc antibody index were retrospectively studied in
relation to the clinical presentation in patients diagnosed
with acute LNB. A total of 118 patients with LNB were
categorized into the following groups according to their
symptoms at presentation; group 1: polyradiculoneuritis
(Bannwarth’s syndrome), group 2: isolated facial palsy and
group 3: predominantly meningitic course of the disease. In
addition to the CSF of patients with acute LNB, CSF of 19
patients with viral meningitis (VM) and 3 with neurolues
(NL) were analyzed. There were 97 patients classiﬁed with
deﬁnite LNB, and 21 as probable LNB. Neck stiffness and
fever were reported by 15.3% of patients. Most of these
patients were younger than 50 years. Polyradiculoneuritis
was frequently found in patients older than 50 years.
Lymphopleocytosis was found in all patients. Only 5
patients had a CSF lactate C3.5 mmol/l, and the mean CSF
lactate level was not elevated (2.1 ± 0.6 mmol/l). The
patients with deﬁnite LNB had signiﬁcantly higher lactate
levels than patients with probable LNB. Elevated lactate
levels were accompanied by fever and headache. In the
Reiber nomograms, intrathecal immunoglobulin synthesis
was found for IgM in 70.2% followed by IgG in 19.5%.
Isoelectric focussing detected an intrathecal IgG synthesis
in 83 patients (70.3%). Elevated BB AIs in the CSF were
found in 97 patients (82.2%). Patients with VM showed
lower CSF protein concentration and CSF/serum quotients
of albumin than LNB patients. In acute LNB, all patients
had elevated cerebrospinal ﬂuid (CSF) leukocyte counts. In
contrast to infections by other bacteria, CSF lactate was
lower than 3.5 mmol/l in all but 5 patients. The CSF
ﬁndings did not differ between polyradiculoneuritis, facial
palsy, and meningitis. The CSF in LNB patients strongly
differed from CSF in VM patients with respect to protein
concentration and the CSF/serum albumin quotient.
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Lyme neuroborreliosis (LNB) is the neurological mani-
festation of systemic infection caused by the spirochete
Borrelia burgdorferi (BB) sensu lato. Clinical features of
LNB are diverse and differ in European and American
patients—most probably because of variations in the Bor-
relia species [1, 2].
The diagnosis of LNB is based on a combination of
history, clinical examination, analysis of cerebrospinal
ﬂuid (CSF), and the detection of antibodies against BB in
serum and CSF.
According to the criteria of the German Society of
Neurology (DGN) LNB is probable when typical clinical
symptoms, pleocytosis in the CSF, and positive serum tests
for Borrelia-speciﬁc IgG or IgM are present [3]. The
detection of intrathecal synthesis of speciﬁc anti-Borrelia
antibodies is considered necessary to diagnose deﬁnite
LNB in Germany and other European countries [1, 3, 4],
whereas American criteria do not require an elevated anti-
Borrelia antibody index (AI) [5, 6].
Laboratory conﬁrmation of LNB is hampered by the
low sensitivity of culture and polymerase chain reaction
(PCR) in CSF [7]. Presence of BB-speciﬁc antibodies in
the CSF with evidence of intrathecal production is the
traditional diagnostic gold standard but has limitations
such as low sensitivity in the very early phase of the
disease [1, 2, 4] and can persist for years after eradication
of the infection [8, 9]. In recent years, the B lymphocyte
chemoattractant chemokine CLCX13 has been identiﬁed
as a potentially important biomarker for the diagnosis of
acute LNB [10, 11]. Reported sensitivities and speciﬁci-
ties are high (in a similar range as for AIs), suggesting
that CSF CLCX13 might be a useful addition to the
diagnostic armamentarium, especially in the very early
stage of LNB, where AIs might still be negative. How-
ever, as patient numbers in the published studies are
rather low, further corroboration of these results is nee-
ded. Several other, more or less validated laboratory tests
have been developed to improve diagnosis. Few data are
available on the CSF lactate levels in adults with deﬁnite
acute LNB. The aim of this study was to evaluate CSF
changes in patients with acute LNB.
Methods
Patients
All ﬁles of patients who were coded as ‘‘probable’’ or
‘‘deﬁnite’’ acute LNB upon admission to the Neurological
Department of the University Medical Center Goettingen
during the past 14 years were screened. The diagnosis of
acute LNB was made if in addition to the typical neuro-
logical symptoms and CSF lymphopleocytosis, either IgM
or IgG antibodies for BB were identiﬁed in serum and/or
CSF. Only patients C16 years of age who had received a
lumbar puncture and with a sufﬁcient clinical documenta-
tion were eligible for this investigation. Exclusion criteria
were other putative reasons for inﬂammation in the central
nervous system (CNS) at presentation. Files were screened
for a study on long-term outcome of patients after acute
NB.
To compare the CSF ﬁndings of patients with LNB to
CSF ﬁndings of patients with CSF pleocytosis of other
origins, ﬁles of patients with viral meningitis (VM)
(n = 19) and neurolues (NL) were also screened. More-
over, all ﬁles of patients with NL without concomitant HIV
infection from the last 10 years were included.
The study was approved by the local ethics committee.
Clinical examination
For clinical symptoms, we applied the Scripps Neurologi-
cal Rating Scale (SNRS) [12], which met our needs for
thorough documentation and reproducibility. In addition,
age, fever, number of days from the onset of symptoms to
hospitalization, information on tick bites, and erythema
migrans (EM) were registered.
LNB patients were categorized into the following
groups according to their symptoms at presentation: group
1—polyradiculoneuritis (Bannwarth’s syndrome), group
2—isolated facial palsy, group 3—predominantly menin-
gitic course of the disease.
Laboratory tests
IgM and IgG antibody response to antigens of BB was
determined in serum by sandwich enzyme-linked immu-
nosorbent assays (ELISA) according to the instructions of
the manufacturer (Genzyme Virotech, Ru ¨sselsheim, Ger-
many). The IgM ELISA was based on antigens of Borrelia
afzelii (analytical sensitivity 99%, speciﬁcity 98.8%,
manufacturer’s information). The antigens of the IgG
ELISA were Borrelia afzelii lysate plus VlsE (analytical
sensitivity 99%, speciﬁcity 97%, manufacturer’s informa-
tion). In patients with a positive ELISA response, Western
blots (Borrelia line, Genzyme Virotech, Ru ¨sselsheim,
Germany) were performed to conﬁrm the speciﬁcity of the
antibodies [13]. The antigens investigated were OspC,
VlsE, BmpA, and DbpA for the detection of speciﬁc
antibodies (analytical sensitivity 99%, speciﬁcity 98%,
manufacturer’s information).
The CSF was examined for leukocyte count (pleocytosis
deﬁned as [4 leukocytes/ll), levels of protein, albumin,
and lactate (pathological C2.1 mmol/l). Intrathecal
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munonephelometrically, and the CSF/serum ratios of IgG,
IgA, IgM, and albumin were calculated. IgG, IgA, and IgM
ratios were plotted versus albumin ratios according to the
nomogram of Reiber and Felgenhauer [14].
The presence of an intrathecal production of BB-speciﬁc
antibodies was evaluated by calculation of the BB-speciﬁc
antibody index (AI). For this purpose, a modiﬁed im-
monoassay was used, based on the commercially available
immunoassay plates Enzygnost Borreliosis IgG/IgM of
Siemens Healthcare Diagnostics GmbH, Marburg, Ger-
many. To increase the sensitivity, the secondary antibodies
supplied with the test kit were replaced by anti-IgG or
anti-IgM antibodies from DAKO, Hamburg, Germany.
Arbitrary concentration units were calculated based on a
standard curve derived from seven 2-fold serial dilutions of
a positive standard serum pool to ﬁt an absorbance range of
0.05–2.0. The highest standard concentration (absorption
of approximately 2.0) was deﬁned as 100 arbitrary units.
CSF and serum pairs of every patient had to be analyzed on
the same plate, and the CSF and serum sample were diluted
to yield antibody concentrations that were in similar parts
of the standard curve. Therefore, standard predilution ratios
were 1:30 for CSF and 1:6000 for serum, in case of an
intrathecal immunoglobulin production modiﬁed predilu-
tion ratios were used. Only those extinctions were used for
AI calculation that lay more than 0.1 above the blank
sample and within the simultaneously determined standard
curve.
The AI was calculated according to the formula
(IgCSF BB/Igserum BB)/(IgCSF total/Igserum total). In case of an
overall IgG or IgM synthesis detected by the Reiber–
Felgenhauer nomograms, the denominator IgCSF total/
Igserum total is replaced by Qlim. Qlim is the maximum
ratio of IgCSF total/Igserum total which can be expected at a
given CSF/serum albumin ratio in the absence of intra-
thecal immunoglobulin synthesis (mean ? 3 standard
deviations) [15, 16]. The AI was deﬁned as pathologic
(i.e., indicative of a synthesis of antibodies against BB
antigen within the CNS), when it was C1.5.
Isoelectric focusing was used to detect oligoclonal
intrathecal IgG synthesis [14]. The CSF ﬁndings were
compared between groups.
Statistics
Statistical calculations were performed with GraphPad
Prism software (GraphPad Software, La Jolla, CA, USA).
Data was described by median and interquartile range. To
prove whether our values were normally distributed the
D’Agostino–Pearson normality test was used. For univar-
iate analyses, we used t test of independent samples for
normally distributed data and U test in the absence of
normal distribution. For the comparison of more than two
groups, we used ANOVA or ANOVA on ranks depending
on the distribution of the original data. Contingency tables
were use to analyze the relation of two variables in the
groups of patients younger or older than 50 years, and
statistical signiﬁcance was assessed by Fisher’s exact test.
Correlations (for parametric data Pearson’s correlation
coefﬁcient r, for non-parametric data Spearman’s rank
correlation coefﬁcient rs) between different parameters
were also analyzed. P values B0.05 were considered sta-
tistically signiﬁcant.
Results
Clinical, CSF, and serological ﬁndings
In 118 patients, acute LNB was diagnosed, of which 21
were grouped as probable LNB (AI\1.5 or not per-
formed) and 97 as deﬁnite LNB (AI C 1.5). The mean age
of all patients was 50 ± 17.1 years and the gender ratio
was 40/78 (F/M).
In the cohort, 15.3% of patients presented with headache
and fever. Sixteen of these patients were younger than
50 years (34.6 ± 11.2 years). Patients with headache and
fever displayed more often neck stiffness (n = 18) than
patients with polyradiculitis (5 out of 53) (p = 0.015).
Polyradiculitis was frequently found in patients older than
50 years (age 54.1 ± 15.1 years). The frequency of facial
palsy was not signiﬁcantly different in patients younger
(n = 28) and older than 50 years (n = 19), respectively,
(p = 0.4). One patient presented with stroke, one with
paresis of N. abducens, one with an epileptic seizure, and
two with vertigo.
Clinical symptoms and CSF parameters of the different
groups are summarized in Table 1 and Fig. 1.
Only 5 patients with LNB showed CSF lactate concen-
trations C3.5 mmol/l, and the mean CSF lactate concen-
tration was not elevated (2.1 ± 0.6 mmol/l). The mean
CSF lactate levels of patients with deﬁnite LNB
(2.3 ± 0.7 mmol/l) were slightly but signiﬁcantly higher
(p = 0.002) than the mean CSF lactate levels of patients
with probable LNB (1.8 ± 0.3 mmol/l). Patients with ele-
vated lactate levels (C2.1 mmol/l) [(group 1—32.1%;
group 2—46.8%; group 3—55.6%), n = 49] presented
signiﬁcantly more often with fever and headache (n = 43;
Fisher’s exact test p = 0.02).
Elevated BB AIs in CSF were found in 97 patients
(82.2%). BB IgM AIs were elevated in 72 patients and BB
IgG AIs in 82 patients. Of the 23 patients pre-treated with
antibiotics, 15 patients had elevated BB AIs (65.2%) in
CSF. Symptoms developed in 107 patients within 6 weeks.
The BB AIs of 21 patients were \1.5 (17.8%). Eleven
632 J Neurol (2012) 259:630–636
123patients reported symptoms for 6 weeks or longer prior to
lumbar puncture. Of these patients, 10 had elevated BB AIs
(90.9%).
Intrathecal immunoglobulin synthesis as estimated by
Reiber–Felgenhauer nomogram was found for IgM in
70.2%, followed by IgG in 19.5%. Intrathecal synthesis of
IgM, IgG, and IgA was found in 11 patients.
Isoelectric focussing, more sensitive than the Reiber–
Felgenhauer plots, detected oligoclonal IgG bands indi-
cating IgG synthesis in the CSF in 83 patients (70.3%). The
positive oligoclonal IgG bands were signiﬁcantly more
frequent in patients with polyradiculoneuritis and facial
palsy than in patients with a meningitic course of acute
LNB. This may be a sign of stronger immune responses in
these patients. The differences of BB-speciﬁc AIs and
oligoclonal bands between the groups are summarized in
Table 2.
Neurolues (NL) was diagnosed during the last 10 years
in only 6 patients in our department. Three of them had
concomitant HIV encephalitis. The CSF samples of the
remaining 3 patients with isolated neurolues were ana-
lyzed. All 3 patients were male (100%). The mean age of
patients with NL was 46.2 ± 13.8 years.
Nineteen patients were allocated to the VM group. The
mean age was 38.3 ± 17.3 years, 8 of them were male
(42%). The CSF ﬁndings of patients with acute LNB, VM,
and NL are summarized in the Table 3. The statistical
analysis between these three groups was not possible,
because of the low number of patients with NL; however,
the statistical comparison between LNB patients and VM
patients was performed.
Of the 95 patients in which serum antibodies against BB
were determined quantitatively, BB- speciﬁc IgM concen-
trations were above the cut-off in 68 (71.6%) patients; 60
patients (76.9%) had elevated anti-BB IgG concentrations
in serum. BB-speciﬁc IgM and IgG concentrations below
the cut-off of the ELISA in serum were found in 12
Table 1 Comparison of laboratory parameters between patients with polyradiculoneuritis (group 1), facial palsy (group 2), and patients with a
meningitic course of LNB (group 3)
Parameter Polyradiculoneuritis (n = 53)
age (54.8 ± 15.2)
Facial palsy (n = 47)
age (45.9 ± 18.5)
Meningitic course (n = 18)
age (34.6 ± 11.2)
P
CSF leukocytes [ll
-1] 171.5 (54.5; 354) 210.5 (90.3; 411.8) 345.5 (100.8; 543.3) 0.12
CSF protein [mg/l] 1,339 (779; 2,087) 1,372 (887; 2,003) 942 (553.0; 1,543) 0.16
QAlbumin 9 10
-3 19.8 (9.8; 31.7) 21.0 (12.0; 28.4) 12.6 (8.1; 23.3) 0.23
CSF lactate [mmol/l] 2.0 (1.7; 2.6) 2.0 (1.7; 2.6) 2.4 (1.8; 2.9) 0.56
Descriptive values are median and interquartile range (Q25 and Q75). After using the D’Agostino–Pearson normality test, the Kruskal–Wallis test
was used for statistical comparisons of not normally distributed data (cell count, protein level, and QAlbumin). ANOVA was used for statistic
analysis of normally distributed data (lactate concentration). Between the groups, we could not ﬁnd any signiﬁcant differences
Fig. 1 Symptoms in patients younger versus patients older than
50 years. Polyradiculoneuritis was signiﬁcantly more frequent in
patients older than 50 years. In contrast, a meningitic course of the
disease was more common in patients under 50 years
Table 2 Numbers of patients with positive oligoclonal IgG bands in
CSF and BB-speciﬁc antibody index (AI) in 118 patients diagnosed
with acute LNB
Parameter Polyradiculoneuritis
(n = 53)
Facial
palsy
(n = 47)
Meningitic
course
(n = 18)
P
Positive
oligoclonal
IgG bands
40 35 8 0.03*
Positive BB
AI IgG
45 37 11 0.10
Positive BB
AI IgM
39 34 9 0.15
Group 1 represents patients with polyradiculoneuritis, group 2 patients
with facial palsy and group 3 patients with a meningitic course of
acute LNB. Positive oligoclonal IgG bands were signiﬁcantly more
frequent in patients with polyradiculoneuritis and facial palsy (Chi
square test)
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BB AI IgG, or both in CSF.
In the remaining 23 patients, blood samples were not
tested for antibodies against BB in a separate quantitative
test, as deﬁnite evidence for acute LNB had been estab-
lished previously by typical clinical signs and positive AI
against BB for IgG, IgM, or both in CSF and serum sam-
ples measured simultaneously in the same assay.
Serum CRP was measured in 81 patients, and elevated
levels were found in 11. WBC was measured in all
patients; 14 patients showed leukocytosis (C11,000/ll).
Between the different clinical presentations, we could not
ﬁnd signiﬁcant differences for these laboratory parameters.
Discussion
European LNB is associated with elevated cell count
in the CSF, typically 10–1,000 leukocytes/mm
3 (60%
between 30 and 300 cells/mm
3), mainly B lymphocytes
and plasma cells. Together with the intrathecal immuno-
globulin production with intrathecal IgM dominance and
blood–CSF barrier dysfunction, these typical CSF changes
allow the diagnosis of acute LNB with a speciﬁcity of
96% and sensitivity of 70% [17]. Published data compare
well with our ﬁndings of intrathecal IgM synthesis in
70.2% of the patients and lymphopleocytosis in all
patients. The diagnostic sensitivity of BB-speciﬁc anti-
body production in CSF is about 80% [18]. In our study,
the sensitivity of the elevated BB-speciﬁc antibody index
was 82.2%.
A positive AI may persist for years after successful
therapy [8, 9]. In some cases, the AIs were C1.5 while in
serum BB-speciﬁc antibodies were below the cut-off of the
ELISA [19]. This phenomenon was found in 9 patients in
our study.
After effective treatment of LNB, BB-speciﬁc antibodies
concentrations frequently decrease more rapidly in serum
than in the CSF. This can lead to an increased AI during
recovery.
BB AI negativity in CSF in patients with early LNB has
been documented in series of patients with LNB conﬁrmed
by culture, PCR, or BB antigen demonstration [20, 21]. The
frequency of 18.7% BB AI negativity in our patients with
symptoms lasting \6 weeks is in accordance with fre-
quencies of 10–20% early BB AI negativity reported from
other European centers [15, 17, 22]. These ﬁndings conﬁrm
that BB AIs in the acute phase of LNB have only moderate
sensitivity.
Early antibiotic therapy can abort the humoral immune
response resulting in undetectable or normal BB AI or may
impede the immune switch from IgM to IgG in plasma [23,
24]. On the other hand, one study showed an increased
percentage of B cells in CSF and of intrathecally produced
BB antibodies immediately after initiation of antibiotic
treatment [25]. Our data demonstrate the necessity to
determine the AIs both for BB IgM and IgG.
Patients with LNB with normal leukocyte counts have
been described exceptionally. These patients were either in
the very early stage of the disease or were immunosup-
pressed individuals or were children with an isolated facial
palsy [19]. In our study, all patients had CSF lymphople-
ocytosis, and we have not seen such a case in adults during
our clinical practise.
Studies which investigated the role of CSF lactate levels
for diagnosis of LNB are very rare. For other types of
bacterial meningitis, such as pneumococcal or meningo-
coccal meningitis, a CSF lactate level C3.5 mmol/l is
typical and found in 90% of patients during the acute stage
[17]. In our study, a normal mean CSF lactate level was
found for all patients. However, patients with deﬁnite LNB
showed slightly elevated CSF lactate concentrations com-
pared to the patients with probable LNB. All 5 LNB
patients with CSF lactate levels C3.5 mmol/l had a men-
ingitic course of the diseases. Elevated lactate levels were
signiﬁcantly more often accompanied by fever and head-
ache. With respect to the CSF abnormalities, the most
difﬁcult differential diagnosis of LNB is tuberculous
meningitis. The typical CSF changes during tuberculous
meningitis are lymphopleocytosis (80% between 30 and
300 cells/mm
3), severe blood–CSF barrier dysfunction
and predominant intrathecal IgA synthesis. In contrast to
LNB, patients with neurotuberculosis in general show CSF
lactate levels C3.5 mmol/l [17].
Table 3 CSF ﬁnding in patients with acute lyme neuroborreliosis (LNB), viral meningitis (VM) and neurolues (NL)
Parameter LNB (n = 118) age (50 ± 17.1) VM (n = 19) age (38.3 ± 17.3) NL (n = 3) age (46.2 ± 13.8)
CSF leukocytes [ll
-1] 170.5 (57.0; 369) 97.0 (21.0; 210.0) 65 (7.0; 100.7)
CSF protein [mg/l] 1,232 (697; 1,926) 628 (493.0; 969)* 614 (328.0; 800.0)
QAlbumin 9 10
3 17.2 (9.7; 28.4) 9.1 (7.2; 14.7)* 7.6 (4.0; 11.7)
CSF lactate [mmol/l] 2.0 (1.6; 2.6) 2.1 (1.9; 2.3) 1.5 (1.3; 1.6)
Descriptive values are median and interquartile range (Q25 and Q75)
* p B 0.05 LNB versus VM (Mann–Whitney U test)
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123The most common neurological manifestation of LNB
in Europe in adults is polyradiculoneuritis (Bannwarth’s
syndrome) [26]. In our population polyradiculoneuritis was
also the predominant syndrome which could be found
signiﬁcantly more frequently in patients older than
50 years. During LNB headache occurs in about 40%, but
headache as the prominent symptom without (pseudo)
radicular pain or paresis, i.e., a meningitic syndrome, is
rare in adults [27]. In our study, isolated headache and neck
stiffness was observed in 15.2% of patients younger and in
5 patients older than 50 years. These were the patients in
whom fever and elevated lactate concentrations were also
measured. In another study, headache and stiff neck was
found in 13% of patients but differences in clinical mani-
festation and age of patients were not considered [28]. To
our knowledge, this is the ﬁrst study investigating the
inﬂuence of age on clinical manifestation in an adult
patient cohort with deﬁnite and probable LNB.
In conclusion, acute LNB is a clinical diagnosis sup-
ported by characteristic CSF abnormalities, in particular
elevated CSF leukocyte counts, blood–CSF barrier dys-
function, predominant intrathecal IgM synthesis and ele-
vated BB-speciﬁc AI for IgM or IgG. In contrast to other
forms of bacterial meningitis, the mean CSF lactate level
in our study was not elevated. Lactate can provide rapid
and reliable information, in particular, with respect to the
differential diagnosis tuberculous meningitis. Therefore,
we recommend routine measurement of CSF lactate in
adults with suspected acute LNB. Lactate is unsuitable
for the differentiation of LNB and VM; CSF protein
content and the CSF/serum albumin quotient are more
appropriate.
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